Centre set to amend rules to simplify drug testing process

The Indian government is amending drug regulations to expedite the approval process for clinical trials and bioavailability/bioequivalence studies. These changes aim to reduce the statutory processing time for test license applications from 90 to 45 days. By simplifying procedures and reducing the number of license applications, the government anticipates faster drug development and approval, benefiting stakeholders and optimizing resource allocation.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Kijh5TH
via IFTTT